Package 13668-268-31
Brand: carbamazepine
Generic: carbamazepinePackage Facts
Identity
Package NDC
13668-268-31
Digits Only
1366826831
Product NDC
13668-268
Description
2500 TABLET in 1 BOTTLE (13668-268-31)
Marketing
Marketing Status
Brand
carbamazepine
Generic
carbamazepine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2b305f64-7c1a-4cf6-a4ad-57326eb4c874", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "upc": ["0313668268300"], "unii": ["33CM23913M"], "rxcui": ["308973", "308979"], "spl_set_id": ["97e6e175-75e8-437b-b457-ddb1ae4e857d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (13668-268-01)", "package_ndc": "13668-268-01", "marketing_start_date": "20091023"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (13668-268-05)", "package_ndc": "13668-268-05", "marketing_start_date": "20091023"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (13668-268-10)", "package_ndc": "13668-268-10", "marketing_start_date": "20091023"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (13668-268-30)", "package_ndc": "13668-268-30", "marketing_start_date": "20091023"}, {"sample": false, "description": "2500 TABLET in 1 BOTTLE (13668-268-31)", "package_ndc": "13668-268-31", "marketing_start_date": "20091023"}], "brand_name": "CARBAMAZEPINE", "product_id": "13668-268_2b305f64-7c1a-4cf6-a4ad-57326eb4c874", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "13668-268", "generic_name": "CARBAMAZEPINE", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARBAMAZEPINE", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA077272", "marketing_category": "ANDA", "marketing_start_date": "20091023", "listing_expiration_date": "20261231"}